BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1086507)

  • 1. Prolonged treatment with tolfenamic acid in inflammatory rheumatic diseases.
    Kajander A; Martio J; Mutru O; Gothoni G
    Scand J Rheumatol; 1976; 5(3):158-60. PubMed ID: 1086507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term therapy with tolfenamic acid pINN. A clinical and toxicological study with special reference to clinical and chemical laboratory parameters.
    Sørensen K; Christiansen LV
    Scand J Rheumatol Suppl; 1977; (20):1-7. PubMed ID: 305110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies with tolfenamic acid in rheumatic disorders.
    Ardia A; Franchini S; Baggio A; Cornelli U
    Pharmacol Toxicol; 1994; 75 Suppl 2():66-71. PubMed ID: 7816787
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolfenamic acid: clinical experience in rheumatic diseases.
    Isomäki H
    Pharmacol Toxicol; 1994; 75 Suppl 2():64-5. PubMed ID: 7816786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolfenamic acid in the treatment of rheumatoid arthritis.
    Rejholec V; Vapaatalo H; Tokola O; Gothoni G
    Scand J Rheumatol Suppl; 1979; (24):9-12. PubMed ID: 373086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tolfenamic acid in rheumatoid arthritis.
    Kajander A; Laine V; Gothoni G
    Scand J Rheumatol; 1972; 1(2):91-3. PubMed ID: 4572954
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative, double-blind study on tolfenamic acid in the treatment of rheumatoid arthritis.
    Rejholec V; Vapaatalo H; Tokola O; Gothoni G
    Scand J Rheumatol Suppl; 1979; (24):13-6. PubMed ID: 373084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative clinical study of a new antirheumatic agent, tolfenamic acid (Clotam), and phenylbutazone in rheumatoid arthritis.
    Nyfos L
    Scand J Rheumatol Suppl; 1979; (24):5-7. PubMed ID: 373085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug.
    Krymchantowski AV; Barbosa JS
    Arq Neuropsiquiatr; 2001 Sep; 59(3-B):708-11. PubMed ID: 11593269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrogenic diabetes insipidus induced by lobenzarit disodium treatment in patients with rheumatoid arthritis.
    Sakane N; Yoshida T; Umekawa T; Miyazaki R; Kondo M
    Intern Med; 1996 Feb; 35(2):119-22. PubMed ID: 8680099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo.
    Mikkelsen B; Pedersen KK; Christiansen LV
    Acta Neurol Scand; 1986 Apr; 73(4):423-7. PubMed ID: 3727918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks.
    Tokola RA; Kangasniemi P; Neuvonen PJ; Tokola O
    Cephalalgia; 1984 Dec; 4(4):253-63. PubMed ID: 6394143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolfenamic acid versus propranolol in the prophylactic treatment of migraine.
    Kjaersgård Rasmussen MJ; Holt Larsen B; Borg L; Soelberg Sørensen P; Hansen PE
    Acta Neurol Scand; 1994 Jun; 89(6):446-50. PubMed ID: 7976233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine: therapeutic effects in rheumatic diseases.
    Amor B; Dougados M
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):218-23. PubMed ID: 3289207
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the therapeutic action and tolerance of diphenpyramide in the treatment of rheumatic diseases].
    Cavazzuti F
    Clin Ter; 1977 Dec; 83(5):469-81. PubMed ID: 305328
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of a new non-steroid, anti-inflammatory drug, ketoprofen, in the therapy of rheumatic diseases].
    Accardo S; Traverso A; Caraffa M; Ferretti A; Moreno M
    Minerva Med; 1978 Oct; 69(51):3523-30. PubMed ID: 310527
    [No Abstract]   [Full Text] [Related]  

  • 17. Tolfenamic acid downregulates β-catenin in colon cancer.
    Ha T; Lou Z; Baek SJ; Lee SH
    Int Immunopharmacol; 2016 Jun; 35():287-293. PubMed ID: 27089389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third World conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992.
    Day RO; Brooks PM; Williams KM; Graham GG
    Agents Actions; 1993 Mar; 38(3-4):iv-viii. PubMed ID: 8213341
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-inflammatory efficacy versus gastrointestinal safety: a dilemma resolved? Introduction.
    Bach GL
    Scand J Rheumatol Suppl; 1992; 96():5-6. PubMed ID: 1439625
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolfenamic acid is as effective as ergotamine during migraine attacks.
    Hakkarainen H; Vapaatalo H; Gothoni G; Parantainen J
    Lancet; 1979 Aug; 2(8138):326-8. PubMed ID: 89390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.